Loading
NYSEHealthcareMedical - Care Facilities
Latest quote
$3.19
+$0.09 · +2.90%
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Regular session
$3.19
+$0.09 · +2.90%
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
52-week range
Current $3.19
Historical prices · Market data may be delayed.
GoAI Score
Hold
Valuation
54
Fair Value
Sentiment
52
Mixed
Risk
66
High Risk
Momentum
53
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
52-week range
Current $3.19
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 460.51M CNY | 383.96M CNY | 537.4M CNY | 472.09M CNY | 485.63M CNY |
| Cost of goods sold | 434.69M CNY | 463.12M CNY | 614.01M CNY | 624.49M CNY | 542.53M CNY |
| Gross profit | 25.82M CNY | −79.16M CNY | −76.61M CNY | −152.41M CNY | −56.9M CNY |
| Selling, general, and administrative | 265.15M CNY | 453M CNY | 386.38M CNY | 372.64M CNY | 401.42M CNY |
| Operating expenses | 265.15M CNY | 453M CNY | 386.38M CNY | 372.64M CNY | 401.42M CNY |
| Interest income | 9.68M CNY | 13.98M CNY | 10.83M CNY | 10.02M CNY | 5.89M CNY |
| Interest expense | 152.33M CNY | 193.2M CNY | 165.67M CNY | 120.36M CNY | 73.79M CNY |
| Depreciation and amortization | 149.26M CNY | 130.76M CNY | 128.45M CNY | 132.81M CNY | 104.08M CNY |
| Operating income | −239.33M CNY | −532.16M CNY | −462.99M CNY | −525.05M CNY | −458.32M CNY |
| Net income | −92.81M CNY | −308.24M CNY | −297.66M CNY | −489.66M CNY | −271.43M CNY |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
$0.99
2015 complete year+526.1% since 2011
$0.1581
2,011
$8.71
2,014
$0.99
2,015
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Dec 23, 2015 | $0.99Special | Dec 28, 2015 | Jan 29, 2016 |
Dividend | Aug 5, 2014 | $0.90Special | Aug 7, 2014 | Sep 30, 2014 |
Dividend | Jan 16, 2014 | $0.71Annual | Jan 21, 2014 | Jan 30, 2014 |
Dividend | Jan 16, 2014 | $0.72Special | Jan 21, 2014 | Jan 30, 2014 |
Dividend | Aug 29, 2011 | $0.18Special | Aug 31, 2011 | Sep 30, 2011 |
Ex-dividend Dec 23, 2015
$0.99
Special
Record Dec 28, 2015 · Payment Jan 29, 2016
Ex-dividend Aug 5, 2014
$0.90
Special
Record Aug 7, 2014 · Payment Sep 30, 2014
Ex-dividend Jan 16, 2014
$0.71
Annual
Record Jan 21, 2014 · Payment Jan 30, 2014
Ex-dividend Jan 16, 2014
$0.72
Special
Record Jan 21, 2014 · Payment Jan 30, 2014
Ex-dividend Aug 29, 2011
$0.18
Special
Record Aug 31, 2011 · Payment Sep 30, 2011
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
